ZA946217B - Therapeutic combination - Google Patents
Therapeutic combinationInfo
- Publication number
- ZA946217B ZA946217B ZA946217A ZA946217A ZA946217B ZA 946217 B ZA946217 B ZA 946217B ZA 946217 A ZA946217 A ZA 946217A ZA 946217 A ZA946217 A ZA 946217A ZA 946217 B ZA946217 B ZA 946217B
- Authority
- ZA
- South Africa
- Prior art keywords
- therapeutic combination
- therapeutic
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939317146A GB9317146D0 (en) | 1993-08-18 | 1993-08-18 | Therapeutic combinations |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA946217B true ZA946217B (en) | 1996-02-19 |
Family
ID=10740659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA946217A ZA946217B (en) | 1993-08-18 | 1994-08-17 | Therapeutic combination |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU7389794A (en) |
GB (1) | GB9317146D0 (en) |
IL (1) | IL110690A0 (en) |
WO (1) | WO1995005179A1 (en) |
ZA (1) | ZA946217B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9501127D0 (en) * | 1995-01-20 | 1995-03-08 | Wellcome Found | Tablet |
GB9512854D0 (en) * | 1995-06-23 | 1995-08-23 | Wellcome Found | Novel formulation |
WO2004103340A1 (en) * | 2003-05-20 | 2004-12-02 | Ranbaxy Laboratories Limited | Water dispersible tablets of lamotrigine |
WO2005051350A2 (en) * | 2003-10-28 | 2005-06-09 | Torrent Pharmaceuticals Limited | Water dispersible tablet |
EP3797764A1 (en) * | 2019-09-27 | 2021-03-31 | Janusz Chupty Contissi | Pharmacological composition for treatment of nervous tissue dysfunction, in particular viral latency, and the use of j05 atc group substances in treatment of nervous tissue dysfunction, in particular viral latency |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS234018B2 (en) * | 1979-06-01 | 1985-03-14 | Wellcome Found | Method of 3,5-diammino-6-1,2,4-triazine derivatives making |
AP160A (en) * | 1987-08-15 | 1991-11-18 | The Wellcome Foundation Ltd | Therapeutic acyclic nucleosides. |
-
1993
- 1993-08-18 GB GB939317146A patent/GB9317146D0/en active Pending
-
1994
- 1994-08-17 AU AU73897/94A patent/AU7389794A/en not_active Abandoned
- 1994-08-17 WO PCT/GB1994/001800 patent/WO1995005179A1/en active Application Filing
- 1994-08-17 ZA ZA946217A patent/ZA946217B/en unknown
- 1994-08-17 IL IL11069094A patent/IL110690A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1995005179A1 (en) | 1995-02-23 |
AU7389794A (en) | 1995-03-14 |
IL110690A0 (en) | 1994-11-11 |
GB9317146D0 (en) | 1993-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9315808D0 (en) | Therapeutic agents | |
GB9300051D0 (en) | Therapeutic agents | |
GB9312891D0 (en) | Therapeutic agents | |
GB9312893D0 (en) | Therapeutic agents | |
GB9309573D0 (en) | Therapeutic agents | |
GB9312806D0 (en) | Therapeutic agents | |
GB9307013D0 (en) | Therapeutic combinations | |
GB9305644D0 (en) | Therapeutic agents | |
ZA946217B (en) | Therapeutic combination | |
GB9308962D0 (en) | Therapeutic agetns | |
GB9306646D0 (en) | Therapeutic agetns | |
GB9323437D0 (en) | Therapy | |
GB9304111D0 (en) | Therapeutic agents | |
GB9300062D0 (en) | Therapeutic agents | |
GB9303843D0 (en) | Therapeutic agents | |
GB9304063D0 (en) | Therapeutic agents | |
GB9316112D0 (en) | Therapeutic agents | |
GB9314486D0 (en) | Therapeutic agents | |
GB9313726D0 (en) | Therapeutic agents | |
GB9304110D0 (en) | Therapeutic agents | |
GB9307306D0 (en) | Therapeutic agents | |
GB9312892D0 (en) | Therapeutic agents | |
GB9312890D0 (en) | Therapeutic agents | |
GB9303243D0 (en) | Therapeutic agents | |
GB9312808D0 (en) | Therapeutic agents |